Antiosteoporotic agent

Antiosteoporotic agent has been studied in 1 paper since 2016: 1 observational study in people. The newest paper, Nov 23, 2016: “Polypharmacy and adverse outcomes after hip fracture surgery”.

Intervention

1 paper studies it1 findingUpdated

See all 1 papers on antiosteoporotic agent

At a glance

The findings reach people, from one lab or study. 1 lab in 1 country.

“use of antiosteoporotic agents, SSRIs, and eye drops predicted rehospitalization after hip fracture surgery”
Polypharmacy and adverse outcomes after hip fracture surgeryJournal of orthopaedic surgery and research2016doi:10.1186/s13018-016-0486-7
Humans: a single group. Cells, worms or flies and mice: nothing yet.
  • 1 lab in 1 country
  • Funders: Crafoordska Stiftelsen and 5 more
  • Humans1

What is antiosteoporotic agent linked with?

1

Studies link antiosteoporotic agent with rehospitalization.

Rehospitalization

upin humans1OR 1.86

1 study
  1. Antiosteoporotic agent predicts rehospitalization in humans after hip fracture surgery (OR 1.86, 95% CI 1.06–3.26).

    Humansafter hip fracture surgery6 months after discharge72.1% femalessn = 272

Latest